ASPIRA logo

Aspira Pathlab & Diagnostics Ltd

ASPIRA·BSE·
97.00 +4.00 (+4.30%)
Market Cap93.87 Cr
PE Ratio48.26
Volume1,148
Day High - Low97.00 - 93.00
52W High-Low135.88 - 49.00
DocStoX Score
3.8/10
Poor
Fair Value
Sign in to see
ROE
0.51%
Weak
P/E
48.26x
Expensive
Debt / Equity
0.27
Low
Industry
Healthcare Services
Healthcare Service Provider
Overall View
Poor

Price performance

Day93.00
97.00
52W49.00
135.88
DocStoX take

Held back by valuation (0.0).

DocStoX score

Low confidence
3.8
/10
Poor
Quality
Modest
ROE 0.5%
Valuation
Expensive
P/E 48.3×
Growth
Slow
Revenue +8.1% 5Y CAGR
Risk
Moderate
D/E 0.27
Momentum
Firm
55% of 52-week range

At a glance

Market Cap
₹94 Cr
52W High / Low
₹136 / ₹49
Dividend Yield
0.00%
Promoter Holding
46.58%
EPS (TTM)
₹2.01
Book Value
₹11.88

Key highlights

  • Loss-making in some of the last 5 years
  • Valuation is weak (0.0/10)
0 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare Services stocks · Healthcare Service Provider

Aspira Pathlab & Diagnostics Ltd peers in Healthcare Services

Other Healthcare Services stocks on the NSE & BSE. See the full Healthcare Services sector list.